Skip to content

Eesketamine combined with propofol on diaphragm movement in patients undergoing painless gastrointestinal endoscopy

Esketamine combined with propofol on diaphragm movement in patients undergoing painless gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115121
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-30
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with gastrointestinal diseases or normal individuals who need a physical examination

Interventions

Control group:Anesthesia induction was initiated 5 minutes after starting nasal cannula oxygenation, with propofol administered intravenously at a dose of 1.5 mg/kg. The propofol dosage was adjusted b
Esketamine Group:After 5 minutes of nasal cannula oxygenation, anesthesia induction was initiated with intravenous propofol at a dose of 1.5 mg/kg. The propofol dosage was adjusted based on the target

Sponsors

Tianjin Binhai New Area Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old; 2. BMI 18~25 kg/m²; 3. ASA I or II grade; 4. No history of allergy to the drugs involved in this study; 5. No history of allergy to the coupling agent; 6. The patient is mentally clear and voluntarily signs the informed consent form for this trial.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular diseases, such as unstable angina pectoris and ischemic heart disease that are not well controlled. 2. A history of hypertension with poor blood pressure control, where elevated blood pressure may lead to serious consequences. 3. Severe hepatic and renal functional impairments. 4. Acute exacerbation of chronic obstructive pulmonary disease, hypercapnia, acute asthma attack, acute respiratory tract infection, or patients highly suspected of having a difficult airway. 5. Patients with severe mental disorders or those who have been taking psychotropic drugs for a long time. 6. Patients with deformities such as scoliosis that severely affect respiratory function. 7. Patients with a history of major thoracic or abdominal surgeries.

Design outcomes

Primary

MeasureTime frame
Diaphragmatic thickness at end inspiration;End-expiratory diaphragm thickness;Diaphragmatic Thickening Score;

Secondary

MeasureTime frame
Mean Arterial Pressure;Heart rate;Blood oxygen saturation;Respiratory rate;

Countries

China

Contacts

Public ContactYing Liu

Tianjin Binhai New Area Hospital of Traditional Chinese Medicine

1251755489@qq.com+86 184 0470 3177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026